A Comparison of Technegas and Xenon-133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy
Phase 3
Terminated
- Conditions
- Lung Structure Determination
- Interventions
- Drug: Xe-133Drug: Technegas
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Cyclomedica Australia PTY Limited
- Target Recruit Count
- 226
- Registration Number
- NCT03054870
- Locations
- ๐บ๐ธ
Mayo Clinic in Jacksonville, FL, Jacksonville, Florida, United States
๐บ๐ธWashington University Medical Center, Barnes-Jewish Hospital - Center for Advanced Medicine, Saint Louis, Missouri, United States
๐บ๐ธScott & White Medical Center, Temple, Texas, United States
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
Phase 3
Terminated
- Conditions
- Pulmonary Embolism
- Interventions
- Drug: Technegas V SPECT imaging
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2015-11-10
- Lead Sponsor
- Cyclomedica Australia PTY Limited
- Target Recruit Count
- 18
- Registration Number
- NCT01458639
- Locations
- ๐บ๐ธ
Columbia University Medical Center, New York, New York, United States
๐บ๐ธBarnes-Jewish Hospital, Washington University, St. Louis, Missouri, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath